Haaland, B., Chopra, A., Acharyya, S., Fay, A. P., & Lopes, G. d. L. (2014). Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma. BioMed Central.

Haaland, Benjamin, Akhil Chopra, Sanchalika Acharyya, André P. Fay, und Gilberto de Lima Lopes. Comparative Effectiveness of Approved First-line Anti-angiogenic and Molecularly Targeted Therapeutic Agents in the Treatment of Good and Intermediate Risk Metastatic Clear Cell Renal Cell Carcinoma. BioMed Central, 2014.

Haaland, Benjamin, et al. Comparative Effectiveness of Approved First-line Anti-angiogenic and Molecularly Targeted Therapeutic Agents in the Treatment of Good and Intermediate Risk Metastatic Clear Cell Renal Cell Carcinoma. BioMed Central, 2014.